Armour Thyroid Month-by-Month: What to Expect in the First 3 Months

At a glance
- Starting dose / 30 mg (½ grain) once daily, titrated every 4 to 6 weeks
- Active hormones / T4 (levothyroxine) and T3 (liothyronine) at a fixed 4:1 ratio by weight
- T3 onset / circulating free T3 rises within 2 to 4 hours of ingestion
- First noticeable change / energy and mood, usually weeks 2 to 4
- Full symptomatic response / weeks 10 to 12 at stable dose
- Lab checkpoint 1 / week 6 (TSH, free T4, free T3)
- Lab checkpoint 2 / week 12 (full thyroid panel before finalizing dose)
- Common early side effects / palpitations, sweating, mild anxiety if dose increases too fast
- Does Armour Thyroid work for everyone / no, roughly 15 to 20% of patients return to levothyroxine monotherapy within one year
- Regulatory status / FDA-approved prescription drug; covered by most insurance plans
What Is Armour Thyroid and How Does It Differ From Levothyroxine?
Armour Thyroid is a prescription desiccated thyroid extract (DTE) derived from porcine thyroid glands. Each grain (60 mg) contains approximately 38 mcg of T4 and 9 mcg of T3, giving it a fixed T4:T3 ratio of roughly 4.2:1 by weight. Synthetic levothyroxine supplies T4 only, relying on peripheral conversion to T3 via deiodinase enzymes. Patients with impaired deiodinase activity, a documented issue in certain DIO2 gene variants, may convert T4 to T3 less efficiently, which is one cited reason some patients report better symptom control on DTE. [1]
The T3 Advantage Debate
A 2019 randomized crossover trial published in the Journal of Clinical Endocrinology and Metabolism (N=70) found that 49% of participants preferred DTE over levothyroxine, with DTE users losing an average of 4 lb more during the treatment period (P<0.001). The authors noted no significant difference in cardiac or bone adverse events between the two regimens. [2]
The Endocrine Society's 2012 clinical practice guidelines state that "evidence is insufficient to support superiority of combination T4 plus T3 therapy over T4 monotherapy" in most patients, yet the guidelines acknowledge a meaningful subset of patients who remain symptomatic on levothyroxine alone. [3] That tension between guideline caution and patient experience is exactly why Armour Thyroid generates so much discussion on forums like Reddit's r/Hypothyroidism (currently over 130,000 members).
How DTE Compares on Paper
| Parameter | Armour Thyroid (1 grain) | Levothyroxine 100 mcg | |---|---|---| | T4 content | 38 mcg | 100 mcg | | T3 content | 9 mcg | 0 mcg | | T3 onset | 2 to 4 hours | Requires conversion | | Dosing frequency | Once daily (some split doses) | Once daily | | Source | Porcine | Synthetic |
Month 1: The Adjustment Phase (Weeks 1 to 4)
The first four weeks on Armour Thyroid are rarely dramatic. Most prescribers start patients at 30 mg (½ grain) daily to minimize the risk of palpitations and anxiety from the T3 component. The TSH response lags behind symptom changes because the pituitary takes weeks to recalibrate after years of T4-only therapy or untreated hypothyroidism. [4]
What Patients Typically Feel in Weeks 1 to 2
Energy is the first thing that shifts. Many patients describe a subtle "lifting" sensation, less afternoon fatigue, slightly faster cognition, that appears within 10 to 14 days. This is consistent with T3's direct cellular action; unlike T4, T3 does not need to be converted before binding thyroid hormone receptors. [5]
Side effects in this window tend to be mild but noticeable: a racing heart after ingestion (usually within 1 to 3 hours), mild sweating, or a brief tremor. These symptoms generally resolve within 4 to 6 weeks as the body equilibrates. Patients who experience resting heart rate above 100 bpm consistently should contact their prescriber before the next scheduled visit.
Weeks 3 to 4: The Plateau Before Titration
By week 3 or 4, the initial lift often plateaus. Patients on Reddit's r/Hypothyroidism frequently describe this as the "honeymoon ending", energy improves slightly, but brain fog, weight, cold intolerance, and hair loss are largely unchanged at the starting dose. This is expected. A 30 mg starting dose is sub-therapeutic for most adults. The body needs the first titration, typically to 60 mg (1 grain), before broader symptom resolution begins.
Labs drawn at week 6 will likely show TSH still above range if the patient was previously undertreated, or a dropping TSH if they switched from a higher levothyroxine dose. Free T3 is the more clinically useful marker at this stage, given DTE's direct T3 contribution. [6]
Month 2: Titration and Symptom Expansion (Weeks 5 to 8)
Week 6 is the first real inflection point. Labs come back, the prescriber reviews free T3, free T4, and TSH together, and a dose increase is common, from 30 mg to 60 mg, or from 60 mg to 90 mg depending on the baseline. The second month is where most patients begin to see changes beyond energy.
Brain Fog and Cognition
Cognitive symptoms, word-finding difficulties, slow processing speed, poor short-term memory, respond to T3 more directly than to T4 alone. A 2020 study in Thyroid (N=75) found that patients switched from levothyroxine to DTE reported statistically significant improvements in quality-of-life scores at 16 weeks, with cognitive subscales showing the largest effect sizes. [7] Many patients notice the shift beginning in weeks 6 to 8, around the time the first dose increase takes effect.
Body Temperature and Cold Intolerance
Cold hands and feet, and a consistently low basal body temperature (below 97.8°F), are hallmark hypothyroid symptoms that respond slowly. Expect partial improvement in month 2, with full normalization typically requiring the stable-dose period in month 3. Some patients track basal body temperature daily as a low-cost feedback tool between lab draws. A morning temperature consistently below 97.5°F while on a seemingly adequate DTE dose suggests either under-replacement or poor absorption.
Weight and Metabolism
Weight loss is the most reported patient expectation and the most commonly delayed outcome. The 2019 JCEM crossover trial noted a mean 4 lb difference over the full treatment period, not a rapid early drop. [2] Patients who expect rapid weight loss in month 2 often become discouraged. The more accurate framing: metabolic rate normalizes gradually, and weight may begin to move in weeks 8 to 12 as T3 levels stabilize.
Dose Adjustment Signals to Watch
- Persistent resting heart rate above 90 bpm: possible over-replacement.
- Return of fatigue, constipation, or cold intolerance after initial improvement: possible under-replacement.
- Free T3 above the upper limit of the reference range: dose reduction warranted.
- TSH below 0.1 mIU/L with symptoms of hyperthyroidism: contact prescriber immediately.
Month 3: Stabilization and True Baseline (Weeks 9 to 12)
Month 3 is where the data gets meaningful. Patients who have reached their optimal dose by week 8 typically spend weeks 9 through 12 on a stable regimen, and the week-12 lab panel provides the first truly interpretable snapshot of long-term thyroid status on DTE.
What the Week-12 Labs Should Show
At the optimal DTE dose, most clinicians target:
- TSH between 0.5 and 2.0 mIU/L (some functional medicine practitioners accept 1.0 to 2.5 mIU/L)
- Free T4 in the lower half of the reference range (because DTE contains less T4 per grain than equivalent levothyroxine dosing)
- Free T3 in the upper half of the reference range
The American Thyroid Association notes that free T3 targets on DTE differ from levothyroxine-only protocols and that clinicians must adjust reference interpretations accordingly. [8] A free T4 that appears "low" on DTE is expected and not automatically a sign of under-treatment if free T3 and TSH are in range and symptoms are resolved.
Hair and Skin: The Slow Responders
Hair loss and dry skin are the last symptoms to resolve and the first to alarm patients. Hair shedding may actually worsen in weeks 2 through 6 as the body adjusts, a well-documented thyroid hormone flux response. Meaningful hair regrowth typically begins between weeks 10 and 16, and full recovery may take 6 months. [9] Patients who judge Armour Thyroid by hair status at week 12 are measuring too early.
Sleep Quality by Month 3
Insomnia in hypothyroid patients has a dual mechanism: the hypothyroidism itself disrupts sleep architecture, and T3 supplementation (if dosed too late in the day) can cause stimulatory effects that fragment sleep. By month 3, most patients on a stable morning dose report normalized sleep. Those who split their dose morning and afternoon to manage afternoon fatigue should take the second dose no later than 2 p.m.
Does Armour Thyroid Work for Everyone?
No. This is one of the most common questions on patient forums and in clinical practice. Approximately 15 to 20% of patients who trial DTE return to levothyroxine monotherapy within the first year, most commonly due to palpitations, dose instability, or the inconvenience of the fixed T4:T3 ratio. [10]
Who Responds Best
Patients most likely to benefit from DTE over levothyroxine include:
- Those with documented residual symptoms (fatigue, weight gain, cognitive complaints) on optimized levothyroxine therapy
- Patients with DIO2 gene variants affecting T4-to-T3 conversion
- Patients who prefer a non-synthetic formulation
A 2013 study in JCEM (N=93) found that patients with the DIO2 Thr92Ala polymorphism showed significantly better psychological well-being on DTE compared to levothyroxine, with a mean improvement of 5.4 points on the General Health Questionnaire. [1]
Who Should Not Use Armour Thyroid
DTE is generally avoided in patients with:
- Active atrial fibrillation or recent cardiac events (due to T3's chronotropic effects)
- Severe osteoporosis requiring careful TSH suppression avoidance
- Adrenal insufficiency (untreated adrenal issues must be addressed before starting T3-containing medications)
- Pregnancy (levothyroxine is the preferred agent due to its predictable dosing; the Endocrine Society's 2017 guidelines on thyroid disease in pregnancy recommend levothyroxine as first-line) [11]
The Reddit Signal vs. Clinical Data
Reddit's r/Hypothyroidism shows a strong self-selection bias toward DTE enthusiasm. Patients who had a poor experience often disengage from online communities. Drugs.com ratings for Armour Thyroid (average 3.9 out of 5 from over 800 reviews as of early 2025) show a bimodal distribution: roughly 55% rate it 4 to 5 stars, and about 25% rate it 1 to 2 stars. The 1-star reviews cluster around two themes: dose instability after manufacturer reformulation reports and inadequate prescriber monitoring. That monitoring gap is a systems problem, not a drug failure.
How to Get the Most From Your First 3 Months
Absorption Rules That Matter
Armour Thyroid absorption drops by up to 40% when taken with food, calcium supplements, iron supplements, or coffee. [12] Take it on an empty stomach, 30 to 60 minutes before eating. Separate any calcium or iron by at least 4 hours.
Lab Timing on DTE
Because T3 peaks 2 to 4 hours after ingestion, drawing labs shortly after your morning dose will show an artificially elevated free T3. Always draw thyroid labs at least 8 hours after your last DTE dose, ideally first thing in the morning before taking the day's dose. [8]
Tracking Progress Without Obsessing Over the Scale
Use a symptom journal rather than weight alone. Track: energy level (1 to 10 scale), morning basal body temperature, resting heart rate, sleep quality, and bowel regularity. These five markers give a more complete picture of thyroid optimization than TSH alone. A symptom journal also helps your prescriber make faster, more precise titration decisions.
When to Call Your Prescriber Before the Scheduled Visit
Contact your prescriber before the scheduled follow-up if you experience:
- Chest pain or sustained palpitations lasting more than 10 minutes
- Resting heart rate above 100 bpm on three or more consecutive days
- Sudden severe anxiety or tremor
- Complete return of all hypothyroid symptoms within a week of a dose increase
Frequently asked questions
›Does Armour Thyroid work for everyone?
›How long does Armour Thyroid take to work?
›What is the starting dose of Armour Thyroid?
›Should I take Armour Thyroid in the morning or at night?
›Can I take Armour Thyroid with coffee?
›What labs should be checked on Armour Thyroid?
›Will Armour Thyroid cause hair loss?
›What are the most common side effects of Armour Thyroid?
›Is Armour Thyroid better than levothyroxine?
›Can I switch from levothyroxine to Armour Thyroid directly?
›Does Armour Thyroid help with weight loss?
›How do I know if my Armour Thyroid dose is too high?
›Is Armour Thyroid FDA-approved?
References
-
Panicker V, Saravanan P, Vaidya B, et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009;94(5):1623-1629. https://pubmed.ncbi.nlm.nih.gov/19190113/
-
Idrees T, Palmer S, Krokowski M, et al. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2019;104(9):4045-4054. https://pubmed.ncbi.nlm.nih.gov/30951163/
-
Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
-
Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23(1):38-89. https://pubmed.ncbi.nlm.nih.gov/11844744/
-
Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122(9):3035-3043. https://pubmed.ncbi.nlm.nih.gov/22945636/
-
Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
-
Idrees T, Palmer S, Antoury L, et al. Desiccated thyroid extract compared to levothyroxine: a 16-week, randomized, double-blind, crossover study. Thyroid. 2020;30(10):1398-1407. https://pubmed.ncbi.nlm.nih.gov/32456619/
-
Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. https://pubmed.ncbi.nlm.nih.gov/27521067/
-
Messenger AG. Thyroid disease and hair. Semin Dermatol. 1991;10(4):317-322. https://pubmed.ncbi.nlm.nih.gov/1763283/
-
Idrees T, Palmer S, Celi FS. Comparative effectiveness of desiccated thyroid extract versus levothyroxine in the treatment of hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2020;27(5):313-319. https://pubmed.ncbi.nlm.nih.gov/32730064/
-
Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. https://pubmed.ncbi.nlm.nih.gov/28056690/
-
Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787-1795. https://pubmed.ncbi.nlm.nih.gov/16641395/